Search

Author/Creator Doroshow, Deborah

1. 289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting. (9th November 2020)

Authors:
Marron, Thomas; Kodysh, Julia; Rubinsteyn, Alex; Finnigan, John; Blazquez, Ana; Saxena, Mansi; Meseck, Marcia; O'Donnell, Timothy; Delbeau, Daniela; Galsky, Matthew; Doroshow, Deborah; Miles, Brett; Misiukiewicz, Krysztof; Irie, Hanna; Tiersten, Amy; Parekh, Samir; Posner, Marshall; Wolf, Andrea;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A177
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting. (9th November 2020)

Authors:
Marron, Thomas; Kodysh, Julia; Rubinsteyn, Alex; Finnigan, John; Blazquez, Ana; Saxena, Mansi; Meseck, Marcia; O'Donnell, Timothy; Delbeau, Daniela; Galsky, Matthew; Doroshow, Deborah; Miles, Brett; Misiukiewicz, Krysztof; Irie, Hanna; Tiersten, Amy; Parekh, Samir; Posner, Marshall; Wolf, Andrea;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A316
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations). (2021)

Authors:
Mahdi, Haider; Hafez, Navid; Doroshow, Deborah; Sohal, Davendra; Keedy, Vickie; Do, Khanh T.; LoRusso, Patricia; Jürgensmeier, Juliane; Avedissian, Manuel; Sklar, Jeffrey; Glover, Colin; Felicetti, Brunella; Dean, Emma; Mortimer, Peter; Shapiro, Geoffrey I.; Eder, Joseph Paul
Journal:
JCO precision oncology
Issue:
Volume 5(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. EP017/#425 Comparison of NAPI2B expression from paired tissue samples in a clinical study of upifitamab rilsodotin (UPRI; XMT-1536) supports a strategy of testing in archive material. (4th December 2022)

Authors:
Richardson, Debra; Barve, Minal; Saltos, Andreas; Papadopoulos, Kyriakos; Hays, John; Tolcher, Anthony; Ellard, Susan; Doroshow, Deborah; Mitchell, Paul; Zarwan, Corrine; Werner, Theresa; Anderson, Charles; Spira, Alex; Mileshkin, Linda; Bradshaw, Chelsea; Demars, Leslie; Mosher, Rebecca; Hamilto...
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 3
Page Start:
A55
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial. (March 2022)

Authors:
Marron, Thomas U; Fiel, Maria Isabel; Hamon, Pauline; Fiaschi, Nathalie; Kim, Edward; Ward, Stephen C; Zhao, Zhen; Kim, Joel; Kennedy, Paul; Gunasekaran, Ganesh; Tabrizian, Parissa; Doroshow, Deborah; Legg, Meredith; Hammad, Ashley; Magen, Assaf; Kamphorst, Alice O; Shareef, Muhammed; Gupta, Nami...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 3(2022)
Page Start:
219
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗